Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 1.75B | 2.05B | 2.24B | 2.18B | 1.61B |
Gross Profit | 693.60M | 840.29M | 771.00M | 855.37M | 655.91M |
EBITDA | -48.64M | 42.42M | -289.44M | 32.07M | -376.33M |
Net Income | -326.14M | -248.37M | -539.96M | -138.07M | -532.63M |
Balance Sheet | |||||
Total Assets | 2.55B | 2.78B | 3.09B | 3.42B | 2.45B |
Cash, Cash Equivalents and Short-Term Investments | 309.35M | 416.16M | 473.78M | 536.83M | 773.58M |
Total Debt | 645.94M | 995.01M | 1.01B | 839.04M | 762.34M |
Total Liabilities | 2.24B | 1.76B | 1.79B | 1.67B | 1.30B |
Stockholders Equity | 305.83M | 1.02B | 1.30B | 1.76B | 1.14B |
Cash Flow | |||||
Free Cash Flow | 28.99M | 16.15M | -164.27M | -190.88M | -198.98M |
Operating Cash Flow | 60.70M | 141.81M | 12.15M | -1.71M | 40.39M |
Investing Cash Flow | -92.11M | -77.14M | -182.11M | -959.06M | -351.32M |
Financing Cash Flow | -22.91M | -122.29M | 106.92M | 724.01M | 772.28M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
83 Outperform | £362.38M | 7.50 | 14.43% | 4.74% | 6.19% | -4.44% | |
57 Neutral | HK$24.67B | 3.83 | -3.22% | 5.89% | 0.28% | -59.63% | |
56 Neutral | £471.67M | ― | -27.20% | ― | -14.37% | -28.78% | |
55 Neutral | £507.48M | 48.09 | 6.87% | ― | 9.45% | -57.24% | |
51 Neutral | £370.57M | ― | -62.59% | ― | -15.86% | -18.46% | |
48 Neutral | £209.32M | ― | -96.36% | ― | -16.32% | -202.39% | |
48 Neutral | £682.03M | ― | 890.75% | 0.48% | 2.62% | -129.82% |
THG PLC has announced the sale of Claremont Ingredients, a UK-based flavour manufacturing and development laboratory, to Nactarome Group for approximately £103 million. This move aligns with THG’s strategy to simplify its operations and achieve a net cash balance sheet. The sale represents a significant return on investment, as Claremont was originally acquired for £52 million in 2020. Financially, the disposal will aid in reducing THG’s net leverage and borrowing costs. Operationally, the relationship with Claremont will continue through a long-term supply contract, ensuring Myprotein’s flavour capabilities remain robust. The transaction is expected to impact THG’s EBITDA in the coming years, but the company anticipates double-digit revenue growth for THG Nutrition in the second half of 2025, driven by stable whey prices and strategic pricing approaches to enhance market share.
The most recent analyst rating on (GB:THG) stock is a Sell with a £0.49 price target. To see the full list of analyst forecasts on THG stock, see the GB:THG Stock Forecast page.
THG PLC has announced the sale of Claremont Ingredients, a UK-based flavour manufacturing and development laboratory, to Nactarome Group for approximately £103 million. This divestment aligns with THG’s strategy to simplify its operations and achieve a net cash balance sheet. The sale represents a significant return on investment, as Claremont was acquired for £52 million in 2020. Financially, the disposal will help reduce THG’s net leverage and borrowing costs, although it is expected to decrease the Group’s EBITDA for FY 2025 and FY 2026 by £5 million and £10 million, respectively. The strategic move is part of THG’s broader plan to focus on core strengths and market share growth, particularly for its Myprotein brand, which is expected to see double-digit revenue growth in the second half of 2025.
The most recent analyst rating on (GB:THG) stock is a Sell with a £0.49 price target. To see the full list of analyst forecasts on THG stock, see the GB:THG Stock Forecast page.
THG PLC has announced changes to its Board Committee memberships. Milyae Park, an independent Non-Executive Director, has been appointed to the Audit and Risk Committees and the Sustainability Committee. Additionally, Helen Jones, another independent Non-Executive Director, will now serve as the designated Non-Executive Director for workforce engagement. These changes are expected to enhance the company’s governance and engagement with its workforce, potentially impacting its operational efficiency and stakeholder relations.
The most recent analyst rating on (GB:THG) stock is a Sell with a £0.49 price target. To see the full list of analyst forecasts on THG stock, see the GB:THG Stock Forecast page.
THG PLC, a company operating in the e-commerce and technology sector, announced the successful passage of all resolutions at its recent Annual General Meeting. The resolutions, which included both ordinary and special resolutions, were approved by the required majorities, indicating strong shareholder support. This outcome reflects positively on THG’s governance and strategic direction, potentially reinforcing its market position and stakeholder confidence.
The most recent analyst rating on (GB:THG) stock is a Sell with a £0.49 price target. To see the full list of analyst forecasts on THG stock, see the GB:THG Stock Forecast page.
THG PLC has reported a return to revenue growth in the second quarter of 2025, maintaining its full-year guidance. The Beauty division showed improvement, with a smaller revenue decline compared to the first quarter, driven by strong performance in the UK. The Nutrition segment experienced significant growth, with Myprotein expanding its offline presence globally, including notable retail partnerships in the US, Europe, and Asia. This expansion is expected to boost brand awareness and sales, despite challenges such as elevated milk and whey prices.
The most recent analyst rating on (GB:THG) stock is a Sell with a £0.45 price target. To see the full list of analyst forecasts on THG stock, see the GB:THG Stock Forecast page.
THG PLC, a UK-based company, has announced a change in its major holdings as Frasers Group Plc has increased its voting rights in the company. The acquisition has resulted in Frasers Group holding 12.61% of the voting rights, up from 11.07%, indicating a strategic move by Frasers Group to strengthen its influence within THG. This change in holdings could have implications for THG’s governance and strategic direction, reflecting Frasers Group’s growing interest and potential influence in the company’s future operations.
The most recent analyst rating on (GB:THG) stock is a Buy with a £75.00 price target. To see the full list of analyst forecasts on THG stock, see the GB:THG Stock Forecast page.
THG PLC has announced the publication of its Notice of Annual General Meeting (AGM) and associated Form of Proxy, which have been distributed to shareholders. The AGM is scheduled to take place on June 25, 2025, at THG Studios, with details on participation and resolutions available in the notice. This announcement ensures transparency and shareholder engagement, reinforcing THG’s commitment to corporate governance.
The most recent analyst rating on (GB:THG) stock is a Sell with a £0.49 price target. To see the full list of analyst forecasts on THG stock, see the GB:THG Stock Forecast page.